Kalíumjoðíð G.L. Pharma (Potassium Iodide)

Potassium iodide supplies non‑radioactive iodide ions that saturate the thyroid gland. This saturation competitively inhibits the gland’s ability to absorb radioactive iodine isotopes, thereby reducing the radiation dose delivered to thyroid tissue.

The appropriate dose of potassium iodide is determined by a qualified prescriber based on the specific indication, patient age, weight, and clinical circumstances. Dosage recommendations are not provided here and should follow local medical guidelines.

Safety data for potassium iodide in pregnancy and lactation are limited. Use should be considered only when the potential benefit justifies any possible risk, and it must be discussed with a healthcare professional before administration.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Potassium iodide is a stable inorganic iodide that rapidly saturates the thyroid, making it the preferred choice for emergency thyroid blocking. Other iodine supplements, such as potassium iodate or organic iodine, may have different absorption profiles and are not typically used for radiation protection.

Kalíumjoðíð G.L. Pharma should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture. No special refrigeration is required, but the product should be kept away from direct sunlight and heat sources.

Potassium iodide is administered orally, usually as a tablet or liquid preparation, according to the prescriber’s instructions. It should be taken with water and can be given with or without food, unless otherwise directed by a healthcare professional.

The most serious risks include severe allergic reactions such as anaphylaxis and significant hyperkalemia, which can affect heart rhythm. Patients with known kidney disease, uncontrolled thyroid disorders, or those taking interacting medications should be monitored closely.

Potassium iodide should be avoided in individuals with known hypersensitivity to iodide, severe renal impairment, uncontrolled hyperthyroidism, or in patients taking medications that markedly increase potassium levels unless closely supervised by a physician.